Yalciner, M. Et Al. 2025. Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors. CLINICAL & TRANSLATIONAL ONCOLOGY .

Yalciner, M., YAZGAN, S. C., EYLEMER MOCAN, E., KARAOĞLAN, B. B., BÖLEK, H., YEKEDÜZ, E., ... ÜRÜN, Y.(2025). Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors. CLINICAL & TRANSLATIONAL ONCOLOGY .

Yalciner, Merih Et Al. "Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors," CLINICAL & TRANSLATIONAL ONCOLOGY , 2025

Yalciner, Merih Et Al. "Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors." CLINICAL & TRANSLATIONAL ONCOLOGY , 2025

Yalciner, M. Et Al. (2025) . "Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors." CLINICAL & TRANSLATIONAL ONCOLOGY .

@article{article, author={Merih Yalciner Et Al. }, title={Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors}, journal={CLINICAL & TRANSLATIONAL ONCOLOGY}, year=2025}